Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs

International Journal of Pharmaceutics

Volumn 333, Issue 1-2, 2007, Pages 127-135

  Kotecha, Jignesh ^a,b   Shah, Shailesh ^a   Rathod, Ishwarsinh ^a   Subbaiah, Gunta ^b  

^a L M COLLEGE OF PHARMACY   (India)

^b Torrent Research Centre   (India)

Author keywords

Absorption; Capacity factor; Correlation; Immobilized artificial membrane chromatography; In vitro model

Indexed keywords

ACICLOVIR; AMILORIDE; ATENOLOL; BRETYLIUM; CARBAMAZEPINE; CHLOROTHIAZIDE; CHLORPROMAZINE; CHLORTALIDONE; CIPROFLOXACIN; DEXAMETHASONE; DICLOFENAC; DILTIAZEM; FAMOTIDINE; FUROSEMIDE; GANCICLOVIR; HYDROCHLOROTHIAZIDE; IMIPRAMINE; INDOMETACIN; KETOROLAC; LISINOPRIL; METOLAZONE; NAPROXEN; NORFLOXACIN; PROPRANOLOL; RANITIDINE; TERBUTALINE; TIMOLOL; VERAPAMIL;

ARTICLE; CHROMATOGRAPHY; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG DETERMINATION; HUMAN; IMMOBILIZED ARTIFICIAL MEMBRANE CHROMATOGRAPHY; IN VITRO STUDY; NONLINEAR REGRESSION ANALYSIS; PARTITION COEFFICIENT; PH; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ADMINISTRATION, ORAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; MEMBRANES, ARTIFICIAL; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; NONLINEAR DYNAMICS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 33847188146     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.10.010     Document Type: Article

References (54)

1. Abraham M.H., Takacs-Novak K., and Mitchell R.C. On the partition of ampholytes: application to blood-brain distribution. J. Pharm. Sci. 86 (1997) 310-315
2. Artursson P., and Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175 (1991) 880-885
3. Austin R.P., Davis A.M., and Manners C.N. Partitioning of ionizing molecules between aqueous buffers and phospholipid vesicles. J. Pharm. Sci. 84 (1995) 1180-1183
4. Avdeef A., Barrett D.A., Shaw P.N., Knaggs R.D., and Davis S.S. Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. J. Med. Chem. 39 (1996) 4377-4381
5. Avdeef A. Physicochemical profiling (solubility, permeability and charge state). Curr. Top. Med. Chem. 1 (2001) 277-351
6. Barbato F., La Rotonda M.I., and Quaglia F. Chromatographic indexes on immobilized artificial membranes for local anesthetics: relationships with activity data on closed sodium channels. Pharm. Res. 14 (1997) 1699-1705
7. Beigi F., Gottschcalk I., Hagglund C.L., Haneskog L., Brekkan E., Zhang Y., Osterberg T., and Lundahl P. Immobilized liposome and biomembrane partitioning chromatography of drugs for prediction of drug transport. Int. J. Pharm. 164 (1998) 129-137
8. Bretschneider B., Brandsch M., and Neubert R. Intestinal transport of beta-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm. Res. 16 (1999) 55-61
9. Caldwell G.W., Masucci J.A., Evangelisto M., and White R. Evaluation of the immobilized artificial membrane phosphotidylcholine: drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions. J. Chromatogr. A 800 (1998) 161-169
10. Camenisch G., Folkers G., and van de Waterbeemd H. Review of theoretical passive absorption models: historical background, recent developments and limitations. Pharm. Acta Helv. 71 (1996) 309-327
11. Chan E.C.Y., Tan W.L., Ho P.C., and Fang L.J. Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors. J. Chromatogr. A 1072 (2005) 159-168
12. Chiou W.L. The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology. J. Pharmacokinet. Pharmacodyn. 28 (2001) 3-6
13. Collett A., Sims E., Walker D., He Y.L., Ayrton J., Rowland M., and Warhurst G. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption. Pharm. Res. 13 (1996) 216-221
14. Comer J., and Tam K. Lipophilicity profiles: theory and measurement. In: Testa B., van de Waterbeemd H., Folkers G., and Guy R.H. (Eds). Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical and Computational Strategies (2001), Wiley-VHCA, Zurich 275-304
15. Conradi R.A., Burton P.S., and Borchardt R.T. Physico-chemical and biological factors that influence a drug's cellular permeability by passive diffusion. In: Pliska V., Testa B., and van de Waterbeemd H. (Eds). Lipophilicity in Drug Action and Toxicology (1996), VCH Publishers, Germany 233-252
16. Daniel H., Neugebauer B., Kratz A., and Rehner G. Localization of acid microclimate along intestinal villi of rat jejunum. Am. J. Physiol. 248 (1985) G293-G298
17. Dollery C.T. Therapeutic Drugs. 2nd ed. (1999), Churchill Livingstone, Edinburgh
18. Flanagan S.D., Takahashi L.H., Liu X., and Benet L.Z. Contributions of saturable active secretion, passive transcellular, and paracellular diffusion to the overall transport of furosemide across adenocarcinoma (Caco-2) cells. J. Pharm. Sci. 91 (2002) 1169-1177
19. Friedman D.I., and Amidon G.L. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852. J. Pharm. Sci. 78 (1989) 995-998
20. Fujikawa M., Ano R., Nakao K., Shimizu R., and Akamatsu M. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. Bioorg. Med. Chem. 13 (2005) 4721-4732
21. Genty M., Gonzalez G., Clere C., Desangle-Gouty V., and Legendre J.Y. Determination of passive absorption through the rat intestine using chromatographic indices and molar volume. Eur. J. Pharm. Sci. 12 (2001) 223-229
22. Hansch C., Bjorkroth J.P., and Leo A. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J. Pharm. Sci. 76 (1987) 663-687
23. Hogben C.A.M., Tocco D.J., Brodie B.B., and Schanker L.S. On the mechanism of intestinal absorption of drugs. J. Pharmacol. Exp. Ther. 125 (1959) 275-282
24. Kansy M., Senner F., and Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. 41 (1998) 1007-1010
25. Karlsson A., Widegren H., Green C.E., Hamalainen M.D., Westerlund L., Karlsson R., Fenner K., and van de Waterbeemd H. Biosensor analysis of the interaction between drug compounds and liposomes of different properties: a two-dimensional characterization tool for estimation of membrane absorption. J. Pharm. Sci. 94 (2005) 25-37
26. Kerns E.H., Di L., Petusky S., Farries M., Ley R., and Jupp P. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. J. Pharm. Sci. 93 (2004) 1440-1453
27. Lee K., Ng C., Brouwer K.L., and Thakker D.R. Secretory transport of ranitidine and famotidine across Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 303 (2002) 574-580
28. Liu H., Ong S., Glunz L., and Pidgeon C. Predicting drug-membrane interactions by HPLC: structural requirements of chromatographic surfaces. Anal. Chem. 67 (1995) 3550-3557
29. Liu X.Y., Nakamura C., Yang Q., Kamo N., and Miyake J. Immobilized liposome chromatography to study drug-membrane interactions. Correlation with drug absorption in humans. J. Chromatogr. A 961 (2002) 113-118
30. Matsson P., Bergstrom C.A.S., Nagahara N., Tavelin S., Norinder U., and Artursson P. Exploring the role of different drug transport routes in permeability screening. J. Med. Chem. 48 (2005) 604-613
31. McEwan G.T., and Lucas M.L. The effect of E. coli STa enterotoxin on the absorption of weakly dissociable drugs from rat proximal jejunum in vivo. Br. J. Pharmacol. 101 (1990) 937-943
32. Morse K.L., and Pidgeon C. Importance of the mobile phase in immobilized artificial membrane chromatography. In: Testa B., van de Waterbeemd H., Folkers G., and Guy R. (Eds). Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical and Computational Strategies (2001), Wiley-VHCA, Zurich 429-445
33. Neuhoff S., Ungell A.L., Zamora I., and Artursson P. pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. Eur. J. Pharm. Sci. 25 (2005) 211-220
34. Osterberg T., Svensson M., and Lundahl P. Chromatographic retention of drug molecules on immobilized liposomes prepared from egg phospholipids and from chemically pure phospholipids. Eur. J. Pharm. Sci. 12 (2001) 427-439
35. Pagliara A., Testa B., Carrupt P.A., Jolliet P., Morin C., Morin D., Urien S., Tillement J.P., and Rihoux J.P. Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist. J. Med. Chem. 41 (1998) 853-863
36. Pauletti G.M., and Wunderli-Allenspach H. Partition coefficients in vitro: artificial membranes as a standardized distribution model. Eur. J. Pharm. Sci. 1 (1994) 273-282
37. Pidgeon C., Ong S., Liu H., Qiu X., Pidgeon M., Dantzig A.H., Munroe J., Hornback W.J., Kasher J.S., Glunz L., and Szczerba T. IAM chromatography: an in vitro screen for predicting drug membrane permeability. J. Med. Chem. 38 (1995) 590-594
38. Prentis R.A., Lis Y., and Walker S.R. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). Br. J. Clin. Pharmacol. 25 (1988) 387-396
39. Shore P.A., Brodie B.B., and Hogben C.A. The gastric secretion of drugs: a pH partition hypothesis. J. Pharmacol. Exp. Ther. 119 (1957) 361-369
40. Stenberg P., Norinder U., Luthman K., and Artursson P. Experimental and computational screening models for the prediction of intestinal drug absorption. J. Med. Chem. 44 (2001) 1927-1937
41. Stewart B.H., Chung F.Y., Tait B., Blankley C.J., and Chan O.H. Hydrophobicity of HIV protease inhibitors by immobilized artificial membrane chromatography: application and significance to drug transport. Pharm. Res. 15 (1998) 1401-1406
42. Sugano K., Hamada H., Machida M., Ushio H., Saitoh K., and Terada K. Optimized conditions of bio-mimetic artificial membrane permeation assay. Int. J. Pharm. 228 (2001) 181-188
43. Sugano K., Takata N., Machida M., Saitoh K., and Terada K. Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model. Int. J. Pharm. 241 (2002) 241-251
44. Swaan P.W., Stehouwer M.D., and Tukker J.J. Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril. Biochim. Biophys. Acta 1236 (1995) 31-38
45. Taillardat-Bertschinger A., Carrupt P.A., Barbato F., and Testa B. Immobilized artificial membrane HPLC in drug research. J. Med. Chem. 46 (2003) 655-665
46. Taillardat-Bertschinger A., Galland A., Carrupt P.A., and Testa B. Immobilized artificial membrane liquid chromatography: proposed guidelines for technical optimization of retention measurements. J. Chromatogr. A 953 (2002) 39-53
47. Testa B., Carrupt P.A., Gaillard P., and Tsai R.S. Intramolecular interactions encoded in lipophilicity: their nature and significance. In: Pliska V., Testa B., and van de Waterbeemd H. (Eds). Lipophilicity in Drug Action and Toxicology (1996), VCH Publishers, Germany 49-71
48. van de Waterbeemd H., and Testa B. The parameterization of lipophilicity and other structural properties in drug design. In: Testa B. (Ed). Advances in Drug Research vol. 16 (1987), Academic Press, London 87-227
49. Wohnsland F., and Faller B. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J. Med. Chem. 44 (2001) 923-930
50. Williams D.A., and Lemke T.L. Foye's Principles of Medicinal Chemistry. 5th ed. (2002), Lippincott Williams and Wilkins, Baltimore
51. Yang C.Y., Cai S.J., Liu H., and Pidgeon C. Immobilized artificial membranes-screens for drug-membrane interactions. Adv. Drug Deliv. Rev. 23 (1996) 229-256
52. Yen T.E., Agatonovic-Kustrin S., Evans A.M., Nation R.L., and Ryand J. Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors. J. Pharm. Biomed. Anal. 38 (2005) 472-478
53. Zhao Y.H., Le J., Abraham M.H., Hersey A., Eddershaw P.J., Luscombe C.N., Butina D., Beck G., Sherborne B., Cooper I., and Platts J.A. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 90 (2001) 749-784
54. Zhu C., Jiang L., Chen T.M., and Hwang K.K. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur. J. Med. Chem. 37 (2002) 399-407